All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0863 | Anti-ERCC2 (CBYCJ-069) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-069 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0864 | Anti-ERCC2 (CBYCJ-070) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-070 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0865 | Anti-ERCC2 (CBYCX-102) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCX-102 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0866 | Anti-ERCC2 (4B11) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 4B11 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0867 | Anti-ERCC2 (2F6) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2F6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1763 | Anti-ERCC2 (CBYCJ-069) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-069 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1764 | Anti-ERCC2 (CBYCJ-070) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCJ-070 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1765 | Anti-ERCC2 (CBYCX-102) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCX-102 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1766 | Anti-ERCC2 (4B11) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 4B11 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1767 | Anti-ERCC2 (2F6) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 2F6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION